Literature DB >> 22797721

Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration.

Daniela Galimberti1, Claudio D'Addario, Bernardo Dell'osso, Chiara Fenoglio, Alessandra Marcone, Chiara Cerami, Stefano F Cappa, M Carlotta Palazzo, Beatrice Arosio, Daniela Mari, Mauro Maccarrone, Nereo Bresolin, A Carlo Altamura, Elio Scarpini.   

Abstract

Mutations in progranulin gene (GRN) are the most common cause of autosomal dominant familial frontotemporal lobar degeneration (FTLD). In addition, GRN variability influences the risk to develop the disease in non-carriers (sporadic FTLD). We evaluated progranulin gene (GRN) promoter methylation levels in peripheral blood mononuclear cells isolated from 38 patients with sporadic FTLD compared with 38 controls, and correlate them with GRN mRNA expression rate. The percentage of methylation of the GRN promoter was increased in patients with FTLD compared with controls (61.5 vs. 46.3 %, P < 0.001). A trend towards decreased GRN relative expression was observed in patients compared with controls (threefold decrease over controls, P > 0.05), together with a negative correlation between the degree of GRN promoter methylation and mRNA GRN levels (ρ = -0.1, P > 0.05). GRN promoter methylation was not correlated with age. In conclusion, the degree of methylation of the GRN promoter is increased in patients with FTLD as compared with controls, likely leading to a decreased expression of GRN.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797721     DOI: 10.1007/s10072-012-1151-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

3.  Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis.

Authors:  Maria Serpente; Chiara Fenoglio; Chiara Villa; Francesca Cortini; Claudia Cantoni; Elisa Ridolfi; Francesca Clerici; Alessandra Marcone; Luisa Benussi; Roberta Ghidoni; Filippo Martinelli Boneschi; Salvatore Gallone; Stefano Cappa; Giuliano Binetti; Massimo Franceschi; Innocenzo Rainero; Maria Teresa Giordana; Claudio Mariani; Nereo Bresolin; Elio Scarpini; Daniela Galimberti
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia.

Authors:  Chiara Villa; Laura Ghezzi; Anna M Pietroboni; Chiara Fenoglio; Francesca Cortini; Maria Serpente; Claudia Cantoni; Elisa Ridolfi; Alessandra Marcone; Luisa Benussi; Roberta Ghidoni; Francesca Jacini; Andrea Arighi; Giorgio G Fumagalli; Alessandra Mandelli; Giuliano Binetti; Stefano Cappa; Nereo Bresolin; Elio Scarpini; Daniela Galimberti
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization.

Authors:  Almudena Gómez-Hernández; Eva Sánchez-Galán; José Luis Martín-Ventura; Cristina Vidal; Luis Miguel Blanco-Colio; Mónica Ortego; Melina Vega; Javier Serrano; Luis Ortega; Gonzalo Hernández; José Tunón; Jesús Egido
Journal:  J Cardiovasc Pharmacol       Date:  2006-01       Impact factor: 3.105

6.  Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.

Authors:  Chiara Fenoglio; Daniela Galimberti; Francesca Cortini; John S K Kauwe; Carlos Cruchaga; Eliana Venturelli; Chiara Villa; Maria Serpente; Diego Scalabrini; Kevin Mayo; Laura M Piccio; Francesca Clerici; Diego Albani; Claudio Mariani; Gianluigi Forloni; Nereo Bresolin; Alison M Goate; Elio Scarpini
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

Authors:  R Ghidoni; L Benussi; M Glionna; M Franzoni; G Binetti
Journal:  Neurology       Date:  2008-09-03       Impact factor: 9.910

Review 8.  Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN).

Authors:  Bradley F Boeve; Mike Hutton
Journal:  Arch Neurol       Date:  2008-04

9.  Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.

Authors:  Lingeng Lu; Dionyssios Katsaros; Irene A Rigault de la Longrais; Olga Sochirca; Herbert Yu
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

10.  No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration.

Authors:  Sara Rollinson; Jonathan D Rohrer; Julie van der Zee; Kristel Sleegers; Simon Mead; Sebastiaan Engelborghs; John Collinge; Peter P De Deyn; David M A Mann; Christine Van Broeckhoven; Stuart M Pickering-Brown
Journal:  Neurobiol Aging       Date:  2009-05-14       Impact factor: 4.673

View more
  15 in total

1.  Blood DNA methylation as a potential biomarker of dementia: A systematic review.

Authors:  Peter D Fransquet; Paul Lacaze; Richard Saffery; John McNeil; Robyn Woods; Joanne Ryan
Journal:  Alzheimers Dement       Date:  2017-11-08       Impact factor: 21.566

2.  Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.

Authors:  Carolina Alquézar; Ana de la Encarnación; Fermín Moreno; Adolfo López de Munain; Ángeles Martín-Requero
Journal:  J Psychiatry Neurosci       Date:  2016-06       Impact factor: 6.186

Review 3.  Epigenetics of Alzheimer's disease and frontotemporal dementia.

Authors:  Chendhore S Veerappan; Sama Sleiman; Giovanni Coppola
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

4.  Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.

Authors:  Andrew E Arrant; Anthony J Filiano; Daniel E Unger; Allen H Young; Erik D Roberson
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

5.  Circulating progranulin as a biomarker for neurodegenerative diseases.

Authors:  Roberta Ghidoni; Anna Paterlini; Luisa Benussi
Journal:  Am J Neurodegener Dis       Date:  2012-08-02

Review 6.  ALS and FTD: an epigenetic perspective.

Authors:  Veronique V Belzil; Rebecca B Katzman; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2016-06-09       Impact factor: 17.088

7.  Validation of reference genes for quantitative real-time PCR in valproic acid rat models of autism.

Authors:  Jinlong Zhou; Xiaozheng Zhang; Junrong Ren; Ping Wang; Junfeng Zhang; Zhaoming Wei; Yingfang Tian
Journal:  Mol Biol Rep       Date:  2016-06-10       Impact factor: 2.316

Review 8.  Mechanisms of granulin deficiency: lessons from cellular and animal models.

Authors:  Gernot Kleinberger; Anja Capell; Christian Haass; Christine Van Broeckhoven
Journal:  Mol Neurobiol       Date:  2012-12-13       Impact factor: 5.590

9.  Promoter DNA methylation regulates progranulin expression and is altered in FTLD.

Authors:  Julia Banzhaf-Strathmann; Rainer Claus; Oliver Mücke; Kristin Rentzsch; Julie van der Zee; Sebastiaan Engelborghs; Peter P De Deyn; Marc Cruts; Christine van Broeckhoven; Christoph Plass; Dieter Edbauer
Journal:  Acta Neuropathol Commun       Date:  2013-05-13       Impact factor: 7.801

10.  Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.

Authors:  Veronique V Belzil; Peter O Bauer; Mercedes Prudencio; Tania F Gendron; Caroline T Stetler; Irene K Yan; Luc Pregent; Lillian Daughrity; Matthew C Baker; Rosa Rademakers; Kevin Boylan; Tushar C Patel; Dennis W Dickson; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2013-10-29       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.